chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Blister at site of injection. Size is 1 inch by 0.1 inch.; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 at 00:15 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. The patient had not reported any other health issues. The patient had no known allergies to medications, food or other products. The patient did not receive any concomitant medications. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 12Apr2021 at 00:00, the patient experienced blister at site of injection. Size was 1 inch by 0.1 inch. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of injection site blister was not resolved at the time of this report.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
Tetanus booster given on: DECAVAC - 1-26-07 - correct Booster as last Booster was 1997. DECAVAC - 1-8-08. DECAVAC - 1-9-09. No adverse symptoms as result of.
Peri/myocarditis - chest pain, pending treatment. At this point, just planning on NSAIDs
Headaches and body aches then nose bleeds. Fatigue and emesis last few days. Full body rash for past week and skin hurts to touch. Saw Dr. 4/19/2011.
On 12/22/2021 I started feeling fatigued and had a slight sore throat. The symptoms worsened the following day and I developed a headache and cough, as well. On 12/24/2021, I got the over the counter Covid test and tested myself at 11am and 4pm, and both were positive. The headache, cough with phlegm, sore throat and fatigue continued over the weekend, and day by day I started feeling better. Today, I still have a slight headache and a mild cough with phlegm on occasion. There were about 3 nights that I woke up drenched in sweat.
Patient with 3 COVID vaccinations who admitted with complications from COVID. Provider d/c note: "69-year-old female with a past medical history significant for diabetes, hypertension, sleep apnea, CVA, rheumatoid arthritis, SVT and GERD. She presented to the emergency department on 08/01/2022 with a chief complaint of shortness of breath and sore throat. On arrival she was diagnosed with acute onset hypoxia with COVID infection and possible asthma exacerbation. She was started on steroids, remdesivir as well as supportive care. Her symptoms continued to improve over the course of her stay and she was weaned down oxygen. On day of discharge oxygen walk test was performed and patient did desaturation with exercise so she will be going home with supplemental oxygen. On day of discharge she was ready to go home and felt in improved and stable condition. We discussed her insulin requirements while on steroids, she states that she already does a sliding scale based on her blood sugars at home and is comfortable continuing to do so and will follow-up with her endocrinologist further for any recommendations.  Patient was given strict return precautions to which she verbalized understanding".
My head was aching pretty bad. I took my blood pressure, and it read 200/110; I called my doctor and had to wait for an appointment. I took a second read which was still high but not as damaging as the initial one. When I finally had my doctor's appointment, we discussed what could of caused the elevated blood pressure. They took blood for testing; my T3 levels were higher than expected. I was instructed to stop taking my thyroid medication until my follow-up appointment. I stopped taking it for 5 days, and my blood pressure stabilized to normal. With Hashimoto's, I'm not suppose to go long periods without taking my medication. During the follow-up, they cut the dosage of my thyroid medication in half to keep it from elevating my blood pressure. Since then, my blood pressure has returned to what it used to be with seldom spikes.
pt recvd 2nd dose of vax 9OCT95 & pt IgG screen was neg;No further details were provided;
15MAY induration, erythema, swelling, tingling in arms & around hand 20MAY98;no treatment;
DTaP was indicated for the above patient. DTaP-IPV was given inadvertently. There was no adverse event observed or reported. The purpose of the report is to report a medication error (IPV was not needed or indicated. The child received an extra dose of IPV).
Had an allergic reaction on December 13. My face broke out and I developed an itchiness on my hands, back, and neck. Soon after, I started having daily symptoms of dermatographia. I had a dermatology appointment in which the Dermatologist diagnosed the dermatographia.
Post vaccines, patient experienced a slight rash on face. No acute distress. After monitoring patient for 10 minutes, rash disappeared with no treatment and HR, RR remained stable. No rash or redness at injection sites.
moderate headache; body ache; tender arm; diarrhea; chills; nausea; vomiting; This is a spontaneous report from a contactable Other Health Professional reporting for herself. A 45-year-old female patient (not pregnant) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EL0142), via an unspecified route of administration on 15Jan2021 09:00 at single dose in left arm for COVID-19 immunisation. Patient age at time of vaccination was 45 years. No other vaccine was given within 4 weeks prior to the COVID vaccine. The patient's medical history was not reported. The patient had no allergies to medications, food, or other products. She received unspecified concomitant medications. On 16Jan2021 at 23:45 the patient experienced moderate headache, body ache, and tender arm and 40 hours after the dose, she developed diarrhea, chills, nausea & vomiting lasting 4 hours. All the events were considered non serious. No treatment was received for the events. The events had resolved on an unspecified date in Jan2021. Prior to vaccination the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19.
Patient was injected with a needle that was inadvertently provided to the vaccinators from pharmacy without any content in it (plunger was in fully advanced position, nurse did not advance plunger at all). The vaccinator noticed this upon administration when she went to inject the vaccine after having punctured the skin.  She apologized to the patient and administered a new dose a using new syringe and needle.
4 MO WCC  PEDIARIX AND HIB GIVEN AND ADACEL GIVEN IN ERROR INSTEAD OF PREVNAR THAT WAS INTENDED THIRD IMMUNIZ.
Patient came in Sunday around noon after she received her shot on Friday evening. Her arm was red and swollen from just under the vaccination site to her elbow. She stated that about 2 hours after receiving the Pneumovax shot, her right arm began to swell and turn red around the injection site and that she did have some fever/sweating/chills and the redness and swelling has since moved down her arm. She stated she had been taking  Advil about every 8 hours and had taken 1  Claritin.  She said it did seem slightly better on Sunday  than it was on Saturday. She is going to continue taking Advil and will take Benadryl too. Patient also received her flu shot in the left arm, no issues with the left arm.
Received vaccine on 10/16/14 in left thigh. Pt presented with red, tender spot on same thigh. Around 10/20/14 area doubled in size, became puffy and tender.
Confusion, Headache, Myalgia, Arthralgia, Swelling and pain at the injection site, fatigue, tingling, feeling of heat in feet, chest tightness, eye pain Narrative:
1st 24hr severe blisters (numerous) on labia, perineum & rectum accompanied by itching & pain;thermoscan t99 progressed to blisters on body, head, hair, extremities by 72hr p/onset;
10 Minutes after the vaccine I felt a weird pain in my low abdomen/pelvis for the first time ever. Over the next few weeks the pain got worse and also gave me a persisting fever. It turned out to be an abscess in my GI tract. I saw many different doctors at 2 different practices(one being the  clinic) and nobody knew how this happened. As a result, I was hospitalized 2 times and was given IV antibiotics, and discharged with oral antibiotics both times. Again, the doctors have no idea how this happened.
mom states 10 days p/MMR given on 3SEP91 pt devel t106 & was taken to ER; no abnormal findings on exam; questionable sl rash;
Tdap given 4/28/07 prior to injection - patient reports last tetanus - 1997 checked employee record - no date shows last tetanus - 1997 questioned patient of she had Tdap when other employees approximately 3/16/06 - denies this. Tdap given approximately 40 minutes later information found where she had Tdap 3/16/06. At injection site 1 hour arm sore, no redness or edema including 24 hours later.
stroke ,  speech arm , weakness , unable to speak , grasp idem ,  urgent care , MRI confirmed , doctors appointments , primary Doctors , seeing neurology , Doctor   said no more vaccination  or boosters , what so ever , My mom is being followed up closely This stroke has made it so sad for her , and us .  She has had  covid 19 ammonia   and I did her daughter in May and by grace of god  we lived . Ninety days latter  my mom has vaccination and has stroke so sad . God bless all of you who have to  read sad news .  written by pts daughter ,
Hives, chills, restless leg,  diarrhea, vomiting, sweats,  bloating/swelling, tenderness at site (3 days)
Day 1 post injection noted lumps - swollen area to site with itching and redness, warm to touch. Day 2 post injection site red and warm to touch.
It started with mild pain on the vaccinated left upper arm (no swollen or redness on the site) in AM. Around 2:00 PM the pain on the left upper arm was so severe to the point spontaneous scream with the position change. The same degree of pain continued until night on 7/22/13. The pain subsided considerably on AM on 7/23/13. At 3:00 PM on 7/23/13 the pain was almost gone. Used Tylenol with a minimal help.
Dizzy, lightheaded, weak, dark veins, difficulty breathing and walking, chest pain, heart palpitations, flutter, frequent urination,  fast heart rate.
Began with itch at injection site 7 days after initial dose.  By evening  itching continued with swelling at upper arm, redness, and area was not to touch. Day 8 itching is a bit less, redness, swelling redness continue. Applied cold to area.
Immediate swelling at injection site. Patient was feeling fine, no problems breathing, no rash. Rph applied cold compress and the sweeling decreased.
Information has been received from a consumer concerning her 21 year old daughter with no pertinent medical history and no known drug allergies, who on 01-MAR-2008 was vaccinated with the first dose of GARDASIL (lot# not provided). There was no concomitant medication. In September 2008 ("six months after the first dose"), the patient experienced tiredness, fatigue, exhaustion and anemia. Patient sought unspecified medical attention. No lab/diagnostic studies performed. Therapy with GARDASIL was discontinued. At the time of this report the patient had not recovered from tiredness, fatigue, exhaustion or anemia. Additional information has been requested.
BODY ACHES; COLD SWEATS; COULD NOT SLEEP; FELT BAD; CHILLS; DEBILITATING HEADACHE; This spontaneous report received from a patient via a company representative concerned a patient of unspecified age and sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine  (suspension for injection, route of admin not reported, batch number: Unknown) dose, start therapy date were not reported for prophylactic vaccination. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On an unspecified date, the subject experienced body aches, cold sweats, could not sleep, felt bad, chills, and debilitating headache. The action taken with covid-19 vaccine was not applicable. The outcome of the chills, cold sweats, body aches, debilitating headache, could not sleep and felt bad was not reported. This report was non-serious.
Suspected vaccination failure/Got the shot but just got shingles/Guess this vaccine doesn't work; Got the shot but just got shingles/shingles again on my right hip and butt; This case was reported by a consumer via interactive digital media and described the occurrence of vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   The patient's past medical history included shingles (had shingles many years ago just below right breast and across back).   On an unknown date, the patient received Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure was unknown and the outcome of the shingles was not recovered/not resolved.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine.     Additional Information: GSK receipt date: 28-July-2022 Reporter's comment: The case was received from the patient via interactive digital media. The patient had shingles many years ago just below his/her right breast and across his/her back.  The patient stated that he/she was awful but never missed a day of work.  The patient got the shot a couple of years ago but just got shingles again on his/her right hip and butt. The patient stated miserable but he/she was retired now so did not have had to put clothes on.  The patient guessed this vaccine did not work either. Additional supportive information: This case was considered as suspected vaccination failure since the details regarding the completion of primary vaccination schedule, time to onset and laboratory confirmation of shingles were unknown at the time of reporting. The follow-up could not be possible as no contact details were available.
Vertigo, disorientation, and dizziness beginning late night of 1/29, early morning of 1/30 and continuing to date. Also headache, fatigue, muscle weakness, and pain at injection site directly following injection.
Px had 3.5 inches erythematous, edematous, induration in the injection site, it is alsohot and painful to touch.
First dose pfizer covid vaccine administered. Pt instructed to wait in observation area.  Within few minutes of receiving vaccine, pt reports "difficulty breathing and throat closing up".  Pt given oxygen supplementation.  RRT called. Pt taken to ED.
After the second dosage, did not get my monthly period the following month. In fact, I lost my period for 7 months. Only came back with the help of medications. I never missed periods before.
This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (slight tenderness at the injection site) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 22-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced VACCINATION SITE PAIN (slight tenderness at the injection site). At the time of the report, VACCINATION SITE PAIN (slight tenderness at the injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Pt calls clinic on 4/16/21 about 8:30am to report adverse reaction to vaccine she received the previous day.  Pt reports that while driving home after vaccination she suddenly felt difficulty breathing, dizzy, "like she was going to die". She drove herself to closest ED, and was treated for allergic reaction with epinephrine, pepcid and oral benedryl.  She was released from ED later that same day.  She reports having a "rough night", difficulty sleeping, felt like symptoms of lips tingling, throat tightening return when benedryl was wearing off.  She has an epipen and her husband is home with her. She called her local PCP and has follow up appointment on 4/20/21. Pt calls in afternoon, around 3:00pm and reports no improvement and is taking benedryl more frequently, about every 2-3 hours.  She is advised to return to local ED.
12-24 hours of severe chills.; This is a spontaneous report from a non-contactable consumer. This male consumer reported for himself.  A male patient with unspecified age received a dose of BNT162B2 (BNT162B2, Formulation: Solution for injection, Lot Number: unknown, Expiration date: unknown), via unspecified route, administered on Feb2021 as dose 1, single for COVID-19 immunization. The patient medical history and concomitant medications were not reported. On Feb2021, after the vaccination, the patient experienced 12-24 hours of severe chills. The outcome of the events was recovered on Feb2021.  No follow-up attempts possible. No further information expected.
this patient had already received a flu dose back in January 2022; This case was reported by a nurse via call center representative and described the occurrence of extra dose administered in a 19-year-old female patient who received Flu Seasonal QIV (FluLaval Quadrivalent 2021-2022 season) (batch number 42M9S, expiry date 30th June 2022) for prophylaxis.   Co-suspect products included flu seasonal qiv pre-filled syringe device (Flulaval Tetra Pre-Filled Syringe Device) injection syringe for prophylaxis.   Previously administered products included Flu vaccine (received a dose of Flu vaccine in January 2022 was not manufactured by GlaxoSmithKline).   On 12th May 2022, the patient received FluLaval Quadrivalent 2021-2022 season and Flulaval Tetra Pre-Filled Syringe Device. On 12th May 2022, unknown after receiving FluLaval Quadrivalent 2021-2022 season and Flulaval Tetra Pre-Filled Syringe Device, the patient experienced extra dose administered. On an unknown date, the outcome of the extra dose administered was unknown.   This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences.   Additional Information: GSK receipt date: 16-May-2022 Reporter's comment: Licensed vocational nurse reported that the patient received Flulaval dose and on the day of reporting they realized that this patient had already received a flu dose back in January 2022.  The reporter consented to follow-up. Additional Supportive Information: The patient received Flulaval  as an extra dose of Flu vaccine, which led to extra dose administered.
requested medical records, but never received them; pt had a positive COVID test on 8/28/21; per death certificate, pt died in the hospital with a condition contributing to the cause of death being SARS-COV2
Extremely exhausted; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 60-years-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number- EN6207) via an unspecified route of administration in left arm on 16Mar2021 at 13:00 as single dose for COVID-19 vaccination. Medical history included Glaucoma from an unknown start date and was continuing. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient did not receive any other  vaccines within 4 weeks prior to the COVID vaccine. Concomitant medications included Eye drops generic name unknown (MANUFACTURER UNKNOWN ) for glaucoma since an unknown start date and unknown if ongoing. Allergies to medications, food, or other products were all none. On 17Mar2021 at 09:00, the patient experienced soreness in arm and was extremely exhausted. No treatment was received for the events. The clinical outcome of soreness in arm and extremely exhausted were recovering.   No follow-up attempts are needed. No further information is expected.
Patient was in  seeing a different provider and was given 1st dose (2/3/21) of Covid-19 Moderna.  His 2nd dose (3/4/21)for Covid-19 Pfizer was given @ our facility.  Patient did not communicate to our staff that he had gotten his 1st shot some where else using different vaccine manufacturer.  Patient did not have any adverse reactions.
This spontaneous report was received from a nurse practitioner regarding to multiple unspecified number of patients of unknown age and gender. Patient demographics were not reported. Information on their concurrent conditions, pertinent medical history and drug allergies were not reported. On an unknown dates the patients were vaccinated with improperly stored dose of LIQUID PEDVAX HIB Lot/batch# L038502, expiry date 16-AUG-2018, lot L035878, expiry date 11-AUG-2018 (dose number, route, anatomical location and dose units were not specified), (incorrect product storage). Concomitant medications were not reported. No adverse effects were reported. There was no Product Quality Concerns (PQC) involved. Temperature at which the product was stored was 48 degree Fahrenheit, for 5 minutes. There were no previous temperature excursion reported. Additional information has been requested.
Patient is a 68 y.o. male patient of MD with past medical history of hypertension, hyperlipidemia, coronary artery disease, diastolic congestive heart failure, type 2 diabetes mellitus insulin-dependent, CKD stage IV, moderate obesity body mass index 39, presented with decreased urine output and abnormal labs   Acute kidney injury, ATN, creatinine on admission 4 CKD stage IV, baseline creatinine 2 IV fluid hydration Foley catheter placement Closely monitor urine output and kidney function test Daily BMP and magnesium Follow with  nephrology CT abdomen pelvis showed no hydronephrosis. Serum Cr improved close to baseline   Covid-19 Virus Infection Date of onset of symptoms: 12/18/2022 Symptoms present on admission: Generalized tiredness and fatigue and decreased urine output Date of covid positive test: 12/20/2022 Vaccination status: vaccinated Imaging: Chest x-ray no acute finding Oxygen requirements on admission: Room air Current oxygen requirements: Room air Medical therapy: steroids, will discontinue patient is on room air Consultants following: ID Anticipated special isolation end date: 12/28/2022   Insulin-dependent diabetes mellitus with hyperglycemia Hemoglobin A1c Resume Lantus Insulin sliding scale.   Hypertension Norvasc 5 mg daily Carvedilol 6.25 mg twice daily, increase to 12.5 twice daily, increase to home dose of 25 twice daily Isordil 20 mg 3 times daily, add hydralazine 50 3 times daily   IV hydralazine and labetalol as needed  Coronary artery disease Hyperlipidemia Guideline directed medical therapy Currently on Eliquis and Plavix Echocardiogram 3/22/2022 showed EF 73% with normal LV systolic and diastolic function.  Leukocytosis Concern of acute lower urinary tract infection Broad-spectrum IV antibiotics Urine culture Follow with infectious disease team   Morbid obesity Body mass index 39.3 Encouraged weight loss and lifestyle modification